So-Young International Inc (SY)
1.16
+0.04
(+3.57%)
USD |
NASDAQ |
May 22, 16:00
1.18
+0.02
(+1.72%)
After-Hours: 20:00
So-Young International Max Drawdown (5Y): 97.54% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.54% |
March 31, 2024 | 97.54% |
February 29, 2024 | 97.54% |
January 31, 2024 | 97.54% |
December 31, 2023 | 97.54% |
November 30, 2023 | 97.54% |
October 31, 2023 | 97.54% |
September 30, 2023 | 97.54% |
August 31, 2023 | 97.54% |
July 31, 2023 | 97.54% |
June 30, 2023 | 97.54% |
May 31, 2023 | 97.54% |
April 30, 2023 | 97.54% |
March 31, 2023 | 97.54% |
February 28, 2023 | 97.54% |
January 31, 2023 | 97.54% |
December 31, 2022 | 97.54% |
November 30, 2022 | 97.54% |
October 31, 2022 | 97.54% |
September 30, 2022 | 96.53% |
August 31, 2022 | 96.17% |
July 31, 2022 | 95.98% |
June 30, 2022 | 95.88% |
May 31, 2022 | 95.19% |
April 30, 2022 | 93.55% |
Date | Value |
---|---|
March 31, 2022 | 93.55% |
February 28, 2022 | 89.36% |
January 31, 2022 | 89.26% |
December 31, 2021 | 85.80% |
November 30, 2021 | 82.52% |
October 31, 2021 | 81.37% |
September 30, 2021 | 80.69% |
August 31, 2021 | 73.23% |
July 31, 2021 | 68.61% |
June 30, 2021 | 63.75% |
May 31, 2021 | 63.75% |
April 30, 2021 | 58.83% |
March 31, 2021 | 58.83% |
February 28, 2021 | 58.83% |
January 31, 2021 | 58.83% |
December 31, 2020 | 58.83% |
November 30, 2020 | 58.83% |
October 31, 2020 | 58.83% |
September 30, 2020 | 58.83% |
August 31, 2020 | 58.83% |
July 31, 2020 | 58.83% |
June 30, 2020 | 58.83% |
May 31, 2020 | 58.83% |
April 30, 2020 | 58.83% |
March 31, 2020 | 58.83% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
31.05%
Minimum
May 2019
97.54%
Maximum
Oct 2022
77.11%
Average
81.95%
Median
Max Drawdown (5Y) Benchmarks
Sinovac Biotech Ltd | 25.46% |
CASI Pharmaceuticals Inc | 98.20% |
Zai Lab Ltd | 92.84% |
Gracell Biotechnologies Inc (DELISTED) | -- |
Adagene Inc | -- |